PCI Biotech Holding ASA

OSL-PCIB
Oslo Børs
Healthcare Biotechnology
Global Rank
#43804
Country Rank
#257
Market Cap
5.4 M
Price
0.145
Change (%)
1.34%
Volume
87,230

PCI Biotech Holding ASA's latest marketcap:

5.4 M

As of 08/14/2025, PCI Biotech Holding ASA's market capitalization has reached $5.4 M. According to our data, PCI Biotech Holding ASA is the 43804th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 5.4 M
Revenue (ttm) 661,130.25
Net Income (ttm) -1,611,547.94
Shares Out 37.33 M
EPS (ttm) -0.04
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/29/2025
Market Cap Chart
Data Updated: 08/14/2025

PCI Biotech Holding ASA's yearly market capitalization.

PCI Biotech Holding ASA has seen its market value drop from kr100.44 M to kr55.06 M since 2014, representing a total decrease of 45.19% and an annual compound decline rate (CAGR) of 5.50%.
Date Market Cap(kr) Market Cap(USD) Change (%) Global Rank
08/14/2025 kr55.06 M $5.4 M 25.84% 43804
12/30/2024 kr44.34 M $3.89 M -43.29% 41659
12/29/2023 kr78.2 M $7.68 M 2.2% 38176
12/30/2022 kr76.52 M $7.8 M -85.26% 36842
12/30/2021 kr519.21 M $58.81 M -50.14% 26568
12/30/2020 kr1.04 B $121.36 M -63.57% 19497
12/30/2019 kr2.86 B $325.56 M 192.43% 12309
12/28/2018 kr977.44 M $113.06 M -7.08% 16652
12/29/2017 kr1.05 B $128.18 M 370.66% 16728
12/30/2016 kr223.51 M $25.86 M 275% 22269

Company Profile

PCI Biotech Holding ASA was founded in 2007 in Norway. on the Oslo Børs. With 6 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.